AGEN : Summary for Agenus Inc. - Yahoo Finance

Canadian Markets close in 2 hrs 9 mins

Agenus Inc. (AGEN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.57-0.11 (-2.86%)
As of 1:50PM EDT. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close3.68
Bid3.57 x 2100
Ask3.58 x 3300
Day's Range3.52 - 3.70
52 Week Range2.97 - 7.49
Avg. Volume1,247,301
Market Cap351.5M
PE Ratio (TTM)-2.45
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswireyesterday

    Agenus to Report First Quarter 2017 Financial Results on May 4, 2017; Conference Call to Follow

    LEXINGTON, Mass., April 27, 2017 /PRNewswire/ -- Agenus Inc. (AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, will release its first quarter 2017 financial results before the market opens on Thursday, May 4, 2017. Agenus executives will host a conference call at 11:00 a.m. ET the same day. The call will also be webcast and will be accessible from the company's website at

  • American City Business Journals4 days ago

    First malaria vaccine to be tested in Africa, with boost from Lexington's Agenus

    The World Health Organization said Monday that the world’s first malaria vaccine, which features a key component made by Lexington biotech Agenus, will be available in parts of Africa beginning next year. The WHO’s African regional office said that Ghana, Kenya and Malawi would participate in a pilot program for the injectable vaccine, which was developed by U.K. drug giant GlaxoSmithKline (GSK) with funding from the Bill & Melinda Gates Foundation. The vaccine contains a so-called adjuvant made by Agenus (AGEN), which is designed to boost the body’s immune response.

  • What's in Store for Agenus (AGEN) this Earnings Season?
    Zacks4 days ago

    What's in Store for Agenus (AGEN) this Earnings Season?

    Agenus Inc. (AGEN) is expected to report first-quarter 2017 results later this month or early next month.